Gliclazide: Brands, Price & Uses in Bangladesh
Type 2 Diabetes Mellitus Gliclazide is an established, guideline-supported oral antidiabetic medicine indicated for the treatment of type 2 diabetes mellitus in adults and more.
About Gliclazide
Indications of Gliclazide
Type 2 Diabetes Mellitus
Gliclazide is an established, guideline-supported oral antidiabetic medicine indicated for the treatment of type 2 diabetes mellitus in adults, used as an adjunct to diet and exercise when these measures alone do not adequately control blood glucose. Gliclazide is approved and marketed in numerous countries, including Bangladesh, as monotherapy, and Gliclazide is also commonly used in combination with other oral antidiabetic agents (such as metformin, alpha-glucosidase inhibitors, or DPP-4 inhibitors) or with insulin, when glycemic control is not achieved with a single agent.
Combination Therapy
When type 2 diabetes is not adequately controlled on metformin or another single agent alone, Gliclazide may be added as a second-line agent, consistent with international treatment guidelines; combination use of Gliclazide with other antidiabetic drugs requires the addition of that second agent, and this goal is not achieved by Gliclazide alone.
Dosage & Administration of Gliclazide
The dose of Gliclazide is individualized for each patient based on blood glucose response, and must be determined by a qualified healthcare professional. Gliclazide is available as conventional (immediate-release) tablets, taken once or twice daily, and as modified-release (MR) tablets, taken once daily. The lowest effective dose of Gliclazide should be used, with gradual titration guided by regular blood glucose monitoring.
Side Effects of Gliclazide
Common Side Effects
- Hypoglycemia (low blood sugar) - the most frequent and clinically important side effect of Gliclazide; see Precautions and Warnings.
- Gastrointestinal disturbances such as nausea, vomiting, abdominal pain, diarrhea, or constipation.
- Mild, transient visual disturbances related to changes in blood glucose levels, especially at the start of treatment with Gliclazide.
Less Common / Serious Side Effects (Seek Medical Attention)
- Skin reactions such as rash, itching, or hives caused by Gliclazide; rarely, severe reactions such as Stevens-Johnson syndrome or angioedema.
- Blood disorders (rare) associated with Gliclazide, including low white blood cell count, low platelet count, anemia, or pancytopenia, which may present as unusual bruising, bleeding, infections, or fatigue.
- Liver problems (rare) associated with Gliclazide, including raised liver enzymes, cholestatic jaundice, or hepatitis, which may present as yellowing of the skin/eyes, dark urine, or unusual tiredness.
- Weight gain associated with Gliclazide.
Contraindications of Gliclazide
Gliclazide is contraindicated in patients with:
- Known hypersensitivity to Gliclazide, other sulfonylureas, or sulfonamide-derived drugs.
- Type 1 diabetes mellitus.
- Diabetic ketoacidosis, diabetic pre-coma, or diabetic coma.
- Severe hepatic impairment.
- Severe renal impairment.
- Concurrent use of systemic miconazole (including oral gel).
- Breastfeeding (see Pregnancy and Lactation).
Frequently Asked Questions about Gliclazide
What is Gliclazide used for?
How should I take Gliclazide?
What is the most important side effect of Gliclazide?
Can Gliclazide be used during pregnancy or breastfeeding?
What medicines interact with Gliclazide?
What should I do if I think I have taken too much Gliclazide?
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.